132 related articles for article (PubMed ID: 846625)
1. Vitamin D-induced hypercalcemia in experimental renal failure.
Weisbrode SE; Capen CC
Nephron; 1977; 18(1):26-34. PubMed ID: 846625
[TBL] [Abstract][Full Text] [Related]
2. Morphometric analysis of skeletal response to vitamin D in uremic rats fed a low calcium diet.
Weisbrode SE; Capen CC
Virchows Arch B Cell Pathol Incl Mol Pathol; 1979 Jun; 30(3):275-80. PubMed ID: 43007
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural evaluation of the effects of vitamin D and uremia on bone in the rat.
Weisbrode SE; Capen CC; Nagode LA
Am J Pathol; 1974 Aug; 76(2):359-76. PubMed ID: 4276472
[TBL] [Abstract][Full Text] [Related]
4. Model for skeletal resistance to vitamin D in renal failure.
Weisbrode SE; Capen CC
Fed Proc; 1976 Apr; 35(5):1225-31. PubMed ID: 177317
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of vitamin D3 and 1,25-dihydroxyvitamin D3 on osteomalacia in uremic rats fed a low calcium-low-phosphorus diet.
Weisbrode SE
Am J Pathol; 1981 Jul; 104(1):35-40. PubMed ID: 6266257
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. The effect of metabolic acidosis on vitamin D metabolites and bone histology in uremic rats.
Chan YL; Savdie E; Mason RS; Posen S
Calcif Tissue Int; 1985 Mar; 37(2):158-64. PubMed ID: 3924372
[TBL] [Abstract][Full Text] [Related]
8. Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.
Wong RG; Norman AW; Reddy CR; Coburn JW
J Clin Invest; 1972 May; 51(5):1287-91. PubMed ID: 4341503
[TBL] [Abstract][Full Text] [Related]
9. [Drug-induced hypercalcemia].
Sato K
Clin Calcium; 2006 Jan; 16(1):67-72. PubMed ID: 16397353
[TBL] [Abstract][Full Text] [Related]
10. Adequate dietary vitamin D and calcium are both required to reduce bone turnover and increased bone mineral volume.
Lee AM; Sawyer RK; Moore AJ; Morris HA; O'Loughlin PD; Anderson PH
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():159-62. PubMed ID: 24309068
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of hypercalcemia in nude mice bearing a human renal carcinoma.
Strewler GJ; Wronski TJ; Halloran BP; Miller SC; Leung SC; Williams RD; Nissenson RA
Endocrinology; 1986 Jul; 119(1):303-10. PubMed ID: 3013591
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemic encephalopathy due to vitamin D-induced hypercalcemia in a uremic patient.
Oymak O; Akpolat T; Arik N; Yasavul U; Turgan C; Cağlar S
Nephron; 1994; 66(3):369. PubMed ID: 8190198
[No Abstract] [Full Text] [Related]
13. Zinc nutritional status modifies renal osteodystrophy in uremic rats.
Kimmel PL; Langman CB; Bognar B; Faugere MC; Chawla LS; Watkins DW; Malluche HH
Clin Nephrol; 2001 Dec; 56(6):445-58. PubMed ID: 11770796
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D, desferrioxamine and aluminum-induced bone disease in uremic rats.
Verbeelen D; Smeyers-Verbeke J; van Hooff I; de Roy G
Nephron; 1989; 53(1):54-60. PubMed ID: 2779702
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural evaluation of the interaction of glucocorticoids and vitamin D on bone cells in thyroparathyroidectomized rats.
Weisbrode SE; Capen CC
Am J Pathol; 1976 Sep; 84(3):457-68. PubMed ID: 961822
[TBL] [Abstract][Full Text] [Related]
16. Effect of vitamin D on growth in experimental uremia.
Mehls O; Ritz E; Gilli G; Wangdak T; Krempien B
Am J Clin Nutr; 1978 Oct; 31(10):1927-31. PubMed ID: 707349
[TBL] [Abstract][Full Text] [Related]
17. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
Endo K; Katsumata K; Hirata M; Masaki T; Kubodera N; Nakamura T; Ikeda K; Ogata E
J Bone Miner Res; 2000 Jan; 15(1):175-81. PubMed ID: 10646127
[TBL] [Abstract][Full Text] [Related]
18. Atherogenesis in experimental uremia.
Horsch A; Ritz E; Heuck CC; Hofmann W; Kühne E; Bisson M
Atherosclerosis; 1981; 40(3-4):279-89. PubMed ID: 7332607
[TBL] [Abstract][Full Text] [Related]
19. A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia.
Sato M; Lu J; Iturria S; Stayrook KR; Burris LL; Zeng QQ; Schmidt A; Barr RJ; Montrose-Rafizadeh C; Bryant HU; Ma YL
J Bone Miner Res; 2010 Jun; 25(6):1326-36. PubMed ID: 20200930
[TBL] [Abstract][Full Text] [Related]
20. Interaction of dichloromethylene diphosphonate and vitamin D on bone of thyroparathyroidectomized rats.
Weisbrode SE; Capen CC; Pendley CB
Am J Pathol; 1977 Oct; 89(1):137-52. PubMed ID: 143891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
